CRISPR-Cas基因编辑系统升级：聚焦Cas蛋白和PAM

doi:10.16288/j.yczz.19-297

[an error occurred while processing this directive]

Hereditas(Beijing) ›› 2020, Vol. 42 ›› Issue (3): 236-249.doi: 10.16288/j.yczz.19-297

• Review • Previous Articles Next Articles

Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM

Lianchao Tang, Feng Gu()

State Key Laboratory of Ophthalmology and Optometry, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China

Received:2019-11-12 Revised:2020-02-26 Online:2020-03-20 Published:2020-03-04
Contact: Gu Feng E-mail:fgu@mail.eye.ac.cn
Supported by:
Supported by the National Natural Science Foundation of China No(81201181)

Abstract

Abstract:

The emergence of the gene editing technology, especial CRISPR-Cas (clustered regularly intersected short palindromic repeats and CRISPR associated proteins), has greatly promoted the ability of human beings to transform natural species. It has been widely harnessed for the engineering in the medical, industrial, agricultural and other fields. The key component of the CRISPR-Cas system, the Cas protein, possesses its specific features, including self-activity, recognition site, cutting end and guide RNA. PAM (protein assistant motif) is a number of nucleotides adjacent to the target site, which is very important for the Cas protein to recognize the target sequence and is also the key characteristic of CRISPR-Cas. There are several reported methods for identification of PAM. In this review, we summarize the searching for the Cas protein, the identification of Cas mutants with desired traits and the mapping of the PAM (including the extending of PAM spectrum), in order to provide a reference for the development and optimization of next-generation gene editing tools.

Key words: gene editing, CRISPR-Cas system, Cas protein, PAM, directed evolution

Lianchao Tang, Feng Gu. Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM[J]. Hereditas(Beijing), 2020, 42(3): 236-249.

Figures/Tables 11

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Table 1

Fig. 6

Fig. 7

Fig. 8

Fig. 9

Table 2

References 65

[1]	Bak RO, Gomez-Ospina N, Porteus MH . Gene editing on center stage. Trends Genet, 2018,34(8):600-611.
[2]	Zhang F, Wen Y, Guo X . CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet, 2014,23(R1):R40-R46.
[3]	Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DB, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV, Zhang F. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016, 353(6299): aaf5573.
[4]	Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, Verdine V, Donghia N, Daringer NM, Freije CA, Myhrvold C, Bhattacharyya RP, Livny J, Regev A, Koonin EV, Hung DT, Sabeti PC, Collins JJ, Zhang F . Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 2017,356(6336):438-442.
[5]	Gootenberg JS, Abudayyeh OO, Kellner MJ, Joung J, Collins JJ, Zhang F . Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science, 2018,360(6387):439-444.
[6]	Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F . Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature, 2015,517(7536):583-588.
[7]	Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR . Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016,533(7603):420-424.
[8]	Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY, Shimatani Z, Kondo A. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science, 2016, 353(6305): aaf8729.
[9]	Zong Y, Gao CX . Progress on base editing systems. Hereditas(Beijing), 2019,41(9):777-800.
	宗媛, 高彩霞 . 碱基编辑系统研究进展. 遗传, 2019,41(9):777-800.
[10]	Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A, Liu DR . Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 2019,576(7785):149-157.
[11]	Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P . CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007,315(5819):1709-1712.
[12]	Doudna JA, Charpentier E . Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014,346(6213):1258096.
[13]	Hsu PD, Lander ES, Zhang F . Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014,157(6):1262-1278.
[14]	Van Der Oost J, Westra ER, Jackson RN, Wiedenheft B . Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol, 2014,12(7):479-492.
[15]	Barrangou R, Doudna JA . Applications of CRISPR technologies in research and beyond. Nat Biotechnol, 2016,34(9):933-941.
[16]	Jansen R, Embden JD, Gaastra W, Schouls LM . Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol, 2002,43(6):1565-1575.
[17]	Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E . Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol, 2005,60(2):174-182.
[18]	Shah SA, Erdmann S, Mojica FJ, Garrett RA . Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol, 2013,10(5):891-899.
[19]	Westra ER, Semenova E, Datsenko KA, Jackson RN, Wiedenheft B, Severinov K, Brouns SJ . Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet, 2013,9(9):e1003742.
[20]	Marraffini LA, Sontheimer EJ . Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature, 2010,463(7280):568-571.
[21]	Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E . A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012,337(6096):816-821.
[22]	Mali P, Yang L, Esvelt KM, Aach J, Guell M, Dicarlo JE, Norville JE, Church GM . RNA-guided human genome engineering via Cas9. Science, 2013,339(6121):823-826.
[23]	Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA, Zhang F . Multiplex genome engineering using CRISPR/Cas systems. Science, 2013,339(6121):819-823.
[24]	Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F . Genome engineering using the CRISPR-Cas9 system. Nat Protoc, 2013,8(11):2281-2308.
[25]	Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS, Koonin EV, Sharp PA, Zhang F . In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015,520(7546):186-191.
[26]	Gu F . The new “dark horse” of genome editing tool: FnCpf1 has effective genome editing activity in human cells. Hereditas(Beijing), 2017,39(10):947-949.
	谷峰 . 基因组编辑工具新晋“黑马”:FnCpf1在人类细胞内具备有效基因组编辑活性. 遗传, 2017,39(10):947-949.
[27]	He XB, Gu F . Genome-editing: focus on the off-target effects. Chin J Biotechnol, 2017,33(10):1757-1775.
	何秀斌, 谷峰 . 基因组编辑脱靶研究进展. 生物工程学报, 2017,33(10):1757-1775.
[28]	Schunder E, Rydzewski K, Grunow R, Heuner K . First indication for a functional CRISPR/Cas system in Francisella tularensis. Int J Med Microbiol, 2013,303(2):51-60.
[29]	Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, Van Der Oost J, Regev A, Koonin EV, Zhang F,. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 2015,163(3):759-771.
[30]	Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Konermann S, Severinov K, Zhang F, Koonin EV . Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell, 2015,60(3):385-397.
[31]	Burstein D, Harrington LB, Strutt SC, Probst AJ, Anantharaman K, Thomas BC, Doudna JA, Banfield JF . New CRISPR-Cas systems from uncultivated microbes. Nature, 2016,542(7640):237-241.
[32]	Liu JJ, Orlova N, Oakes BL, Ma E, Spinner HB, Baney KLM, Chuck J, Tan D, Knott GJ, Harrington LB, Al-Shayeb B, Wagner A, Brötzmann J, Staahl BT, Taylor KL, Desmarais J, Nogales E, Doudna JA . CasX enzymes comprise a distinct family of RNA-guided genome editors. Nature, 2019,566(7743):218-223.
[33]	Gao L, Cox D, Yan WX, Manteiga JC, Schneider MW, Yamano T, Nishimasu H, Nureki O, Crosetto N, Zhang F . Engineered Cpf1 variants with altered PAM specificities. Nate Biotechnol, 2017,35(8):789-792.
[34]	Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales AP, Li Z, Peterson RT, Yeh JR, Aryee MJ, Joung JK . Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature, 2015,523(7561):481-485.
[35]	Chen ZL, Zhao HM . A highly sensitive selection method for directed evolution of homing endonucleases. Nucleic Acids Res, 2005,33(18):e154.
[36]	Esvelt KM, Carlson JC, Liu DR . A system for the continuous directed evolution of biomolecules. Nature, 2011,472(7344):499-503.
[37]	Hu JH, Miller SM, Geurts MH, Tang WX, Chen LW, Sun N, Zeina CM, Gao X, Rees HA, Lin Z, Liu DR . Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature, 2018,556(7699):57-63.
[38]	Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, Noda T, Abudayyeh OO, Gootenberg JS, Mori H, Oura S, Holmes B, Tanaka M, Seki M, Hirano H, Aburatani H, Ishitani R, Ikawa M, Yachie N, Zhang F, Nureki O . Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science, 2018,361(6408):1259-1262.
[39]	He X, Wang Y, Yang F, Wang B, Xie H, Gu L, Zhao T, Liu X, Zhang D, Ren Q, Liu X, Liu Y, Gao C, Gu F . Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNA ^Gln-processing system in human cells . J Biol Chem, 2019,294(23):9308-9315.
[40]	Horvath P, Romero DA, Coute-Monvoisin AC, Richards M, Deveau H, Moineau S, Boyaval P, Fremaux C, Barrangou R . Diversity, activity, and evolution of CRISPR loci in streptococcus thermophilus. J Bacteriol, 2008,190(4):1401-1412.
[41]	Deveau H, Barrangou R, Garneau JE, Labonte J, Fremaux C, Boyaval P, Romero DA, Horvath P, Moineau S . Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol, 2008,190(4):1390-1400.
[42]	Mojica FJ, Diez-Villasenor C, García-Martinez J, Almendros C . Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology, 2009,155(Pt 3):733-740.
[43]	Wiedenheft B, Van DE, Bultema JB, Waghmare SP, Zhou K, Barendregt A, Westphal W, Heck AJ, Boekema EJ, Dickman MJ . RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci USA, 2011,108(25):10092-10097.
[44]	Mulepati S, Héroux A, Bailey S . Structural biology. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science, 2014,345(6203):1479-1484.
[45]	Jinek M, Jiang F, Taylor DW, Sternberg SH, Kaya E, Ma E, Anders C, Hauer M, Zhou K, Lin S, Kaplan M, Iavarone AT, Charpentier E, Nogales E, Doudna JA . Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science, 2014,343(6176):1247997.
[46]	Nishimasu H, Ran FA, Hsu PD, Konermann S, Shehata SI, Dohmae N, Ishitani R, Zhang F, Nureki O . Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 2014,156(5):935-949.
[47]	Westra ER, Van Erp PB, Kunne T, Wong SP, Staals RH, Seegers CL, Bollen S, Jore MM, Semenova E, Severinov K, De Vos WM, Dame RT, De Vries R, Brouns SJ, Van Der Oost J. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell, 2012,46(5):595-605.
[48]	Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, Van Der Oost J, Brouns SJ, Severinov K. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci USA, 2011,108(25):10098-10103.
[49]	Elmore J, Deighan T, Westpheling J, Terns RM, Terns MP . DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus. Nucleic Acids Res, 2015,43(21):10353-10363.
[50]	Biswas A, Gagnon JN, Brouns SJ, Fineran PC, Brown CM . CRISPRTarget: bioinformatic prediction and analysis of crRNA targets. RNA Biol, 2013,10(5):817-827.
[51]	Xue C, Seetharam AS, Musharova O, Severinov K, Brouns S JJ, Severin AJ, Sashital DG . CRISPR interference and priming varies with individual spacer sequences. Nucleic Acids Res, 2015,43(22):10831-10847.
[52]	Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR . High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol, 2013,31(9):839-843.
[53]	Karvelis T, Gasiunas G, Young J, Bigelyte G, Silanskas A, Cigan M, Siksnys V . Rapid characterization of CRISPR- Cas9 protospacer adjacent motif sequence elements. Genome Biol, 2015,16:253.
[54]	Leenay RT, Maksimchuk KR, Slotkowski RA, Agrawal RN, Gomaa AA, Briner AE, Barrangou R, Beisel CL . Identifying and visualizing functional PAM diversity across CRISPR-Cas systems. Mol Cell, 2016,62(1):137-147.
[55]	Tang LC, Yang FY, He XX, Xie HH, Liu XY, Fu JH, Xi HT, Lu XS, Liu CB, Song ZM, Qu J, Zhao JZ, Gu F . Efficient cleavage resolves PAM preferences of CRISPR- Cas in human cells. Cell Regen, 2019,8(2):44-50.
[56]	Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F . DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol, 2013,31(9):827-832.
[57]	Zhang YL, Ge XL, Yang FY, Zhang LP, Zheng JR, Tan XF, Jin ZB, Qu J, Gu F . Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells. Sci Rep, 2014,4:5405.
[58]	Tu MJ, Lin L, Cheng YL, He XB, Sun HH, Xie HH, Fu JH, Liu CB, Li J, Chen D, Xi HT, Xue DY, Liu Q, Zhao JZ, Gao CX, Song ZM, Qu J, Gu F . A ‘new lease of life’: FnCpf1 possesses DNA cleavage activity for genome editing in human cells. Nucleic Acids Res, 2017,45(19):11295-11304.
[59]	Sampson TR, Saroj SD, Llewellyn AC, Tzeng YL, Weiss DS . A CRISPR/CAS system mediates bacterial innate immune evasion and virulence. Nature, 2013,497(7448):254-257.
[60]	Zhang Y, Heidrich N, Ampattu BJ, Gunderson CW, Seifert HS, Schoen C, Vogel J, Sontheimer EJ . Processing- independent CRISPR RNAs limit natural transformation in neisseria meningitidis. Molecular Cell, 2013,50(4):488-503.
[61]	Chylinski K, Le Rhun A, Charpentier E . The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol, 2013,10(5):726-737.
[62]	Hirano H, Gootenberg JS, Horii T, Abudayyeh OO, Kimura M, Hsu PD, Nakane T, Ishitani R, Hatada I, Zhang F, Nishimasu H, Nureki O . Structure and engineering of francisella novicida Cas9. Cell, 2016,164(5):950-961.
[63]	Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA . RNA- guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol, 2013,31(3):233-239.
[64]	Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM . Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods, 2013,10(11):1116-11121.
[65]	Yamada M, Watanabe Y, Gootenberg JS, Hirano H, Ran FA, Nakane T, Ishitani R, Zhang F, Nishimasu H, Nureki O. Crystal Structure of the minimal Cas9 from campylobacter jejuni reveals the molecular diversity in the CRISPR-Cas9 systems. Mol Cell, 2017, 65(6): 1109-1121.e3.

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

方法	特点	劣势	Cas蛋白	文献
生物信息学分析	一次能够发现大量结构相似或者功能类似的蛋白; 不需要进行分子实验	需要已知的序列信息	SpCas9	[16]
			SaCas9	[25]
			Cpf1	[11]
			FnCas9	[59]
			NmCas9	[60]
			CjCas9	[61]
			St1Cas9	[40]
			St3Cas9	[40]
基于质粒干扰的耗尽筛选	实验思路简单,将PAM识别与细菌的死亡相偶联	通过盒式诱变制作Cas蛋白突变库, 工作量较大; 需要进行第二代测序	AsCpf1 RR	[33]
基于质粒干扰的耗尽筛选	实验思路简单,将PAM识别与细菌的死亡相偶联	通过盒式诱变制作Cas蛋白突变库, 工作量较大; 需要进行第二代测序	AsCpf1 RVR	[33]
细菌选择性定向进化	将PAM识别与细菌的生存相偶联	需制作Cas蛋白突变库; 毒性质粒表达需要诱导,容易出现假阳性; 操作相对复杂	SpCas9 VQR	[34]
			SpCas9 EQR	[34]
			SpCas9 VRER	[34]
噬菌体辅助连续进化	可以同时进行突变和筛选	筛选过程只利用了Cas蛋白的结合能力, 所以筛选出的Cas蛋白更适合作为一种无切割活性的dCas蛋白	xCas9 3.7	[37]
晶体结构为基础的定点突变	结合晶体结构信息进行直接突变; 无需制备大量突变体	需要获得晶体结构; 突变位点选择不易	FnCas9 RHA	[62]
			SaCas9 KKH	[29]
			SpCas9-NG	[38]

方法	切割环境	筛选方向	特点	Cas蛋白	PAM	文献
生物信息学分析	无	正向	原始信息来自于基因组中spacer,结果可靠; 需要已知的spacer; 无法确保spacer来源的正确性; 获得的PAM信息可能不全面	SpCas9	NGG	[42]
				St1Cas9	NNAGAAW	[40]
				St3Cas9	NGGNG	[40]
				NmCas9	NNNNGATT	[60]
体内切割反应 (PAM 质粒库)	细菌	反向	该方法的PAM覆盖度高; 需要制备深度覆盖的质粒库; 需要构建Cas蛋白稳定表达的宿主; PAM逃逸受靶序列突变或DNA修复影响	SpCas9	NGG	[34,63]
				SpCas9 VQR	NGA	[34]
				SpCas9 EQR	NGAG	[34]
				SpCas9 VRER	NGCG	[34]
				SaCas9	NNGRRT	[34]
				SaCas9 KKH	NNNRRT	[29]
				CasX	TTCN	[31]
				CasY.1	TA	[31]
				St1Cas9	NNRGRA	[34,64]
				NmCas9	NNNNGNNT	[64]
体内切割反应 (crRNA 质粒库)	细菌	正向	提供了一种正向的筛选方式; 噬菌体基因组中展现出来的PAM有限; 构建向导RNA库的费用高于PAM库	FnCpf1	TTN	[25]
体外切割反应	体外	正向或反向	被切割模板量大,可以覆盖更多的潜在 PAM,快速; 需要纯化蛋白、靶向模板容易降解、体外条件可能导致PAM结果产生差异	SpCas9	NGG	[25,52,53]
				SpCas9-NG	NG	[38]
				SaCas9	NNGRRT	[25]
				FnCas9	NGG	[62]
				FnCas9 RHA	YG	[62]
				CjCas9	NNNVRYM	[65]
				St1Cas9	NNRRRA	[25]
					NNAGAAW	[53]
				St3Cas9	NGGNG	[60]
PAM-SCANR	细菌	正向	是一种正向筛选; 采用dCas蛋白,结果可能与以切割为基础分析获得的PAM有差异; 筛选可能会受到阻遏效应波动影响; 操作相对复杂	SpCas9	NGG	[54]
PAM-SCANR	细菌	正向		St1Cas9	NNAGAA	[54]
PAM-DOSE	人类细胞	正向	能够直接在人类细胞中进行Cas蛋白 PAM的确定; 采用正向筛选方式,不用制作大容量的 PAM库; 筛选方法依赖NHEJ修复	SpCas9	NGG	[55]
				SpCas9-NG	NG	[55]
				FnCpf1	YYN	[55]
				LbCpf1	YYN	[55]
				AsCpf1	YYN	[55]
				MbCpf1	YYN	[55]

Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 11

References 65

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhong Bian, Dongping Cao, Wenshu Zhuang, Shuwei Zhang, Qiaoquan Liu, Lin Zhang. Revelation of rice molecular design breeding: the blend of tradition and modernity [J]. Hereditas(Beijing), 2023, 45(9): 718-740.
[2]	Bingzheng Wang, Chao Zhang, Jiali Zhang, Jin Sun. Conditional editing of the Drosophila melanogaster genome using single transcripts expressing Cas9 and sgRNA [J]. Hereditas(Beijing), 2023, 45(7): 593-601.
[3]	Xiaojun Zhang, Kun Xu, Juncen Shen, Lu Mu, Hongrun Qian, Jieyu Cui, Baoxia Ma, Zhilong Chen, Zhiying Zhang, Zehui Wei. A CRISPR/Cas9-Gal4BD donor adapting system for enhancing homology-directed repair [J]. Hereditas(Beijing), 2022, 44(8): 708-719.
[4]	Yuting Han, Bowen Xu, Yutong Li, Xinyi Lu, Xizhi Dong, Yuhao Qiu, Qinyun Che, Ruibao Zhu, Li Zheng, Xiaochen Li, Xu Si, Jianquan Ni. The cutting edge of gene regulation approaches in model organism Drosophila [J]. Hereditas(Beijing), 2022, 44(1): 3-14.
[5]	Dingwei Peng, Ruiqiang Li, Wu Zeng, Min Wang, Xuan Shi, Jianhua Zeng, Xiaohong Liu, Yaoshen Chen, Zuyong He. Editing the cystine knot motif of MSTN enhances muscle development of Liang Guang Small Spotted pigs [J]. Hereditas(Beijing), 2021, 43(3): 261-270.
[6]	Guoling Li, Shanxin Yang, Zhenfang Wu, Xianwei Zhang. Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals [J]. Hereditas(Beijing), 2020, 42(7): 641-656.
[7]	Yingnan Chen, Jing Lu. Application of CRISPR/Cas9 mediated gene editing in trees [J]. Hereditas(Beijing), 2020, 42(7): 657-668.
[8]	Fengyue Hu, Kejian Wang. The STEME system: a novel tool for directed evolution in vivo [J]. Hereditas(Beijing), 2020, 42(3): 231-235.
[9]	Junxia Cao, Youliang Wang, Zhengxu Wang. Advances in precise regulation of CRISPR/Cas9 gene editing technology [J]. Hereditas(Beijing), 2020, 42(12): 1168-1177.
[10]	Qianqian Zhang,Xuan Shang,Wanying Lin,Xiangmin Xu. Effect of genetic modifiers on the clinical severity of β-thalassemia [J]. Hereditas(Beijing), 2019, 41(8): 669-676.
[11]	Xuran Niu,Shuming Yin,Xi Chen,Tingting Shao,Dali Li. Gene editing technology and its recent progress in disease therapy [J]. Hereditas(Beijing), 2019, 41(7): 582-598.
[12]	Hao Ou,Guoling Li,Haoqiang Wang,Guangyan Huang,Gengyuan Cai,Zicong Li,Zhenfang Wu,Xianwei Zhang. MEK inhibitor PD0325901 significantly boosts ssODN-mediated HDR efficiency in porcine fetal fibroblasts [J]. Hereditas(Beijing), 2019, 41(4): 327-336.
[13]	Yunxiao Ren, Rudan Xiao, Xiaomin Lou, Xiangdong Fang. Research advance and application in the gene therapy of gene editing technologies [J]. Hereditas(Beijing), 2019, 41(1): 18-27.
[14]	Gaowei Xin, Xixun Hu, Kejian Wang, Xingchun Wang. Cas9 protein variant VQR recognizes NGAC protospacer adjacent motif in rice [J]. Hereditas(Beijing), 2018, 40(12): 1112-1119.
[15]	Yiou Chen, Ying Bao, Huazheng Ma, Zongyi Yi, Zhuo Zhou, Wensheng Wei. Gene editing technology and its research progress in China [J]. Hereditas(Beijing), 2018, 40(10): 900-915.